SCHEMBL6604025

SCHEMBL6604025

O=c1[nH]c(-c2ccc(Cl)cc2)co1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
MAPT P10636 4/20 0.46
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
THRB P10828 1/20 0.46
TSHR P16473 1/20 0.46
NOTUM Q6P988 2/20 0.42
GCGR P47871 1/20 0.41
KMT2A Q03164 3/20 0.41
PDE10A Q9Y233 2/20 0.41
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
RAB9A P51151 2/20 0.39
IDO1 P14902 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRKDC P78527 1/20 0.39
PTPN11 Q06124 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38658162 0.80 MEN1 (0.46) ALDH1A1MAPTKDM4EGAATSHR
SCHEMBL29144919 0.80 ERCC1 (0.46) ALDH1A1MAPTKDM4EGAANOTUM
SCHEMBL1361865 0.79 MEN1 (0.51) MAPTKDM4EGAANOTUMKMT2A
SCHEMBL38657735 0.78 BRD4 (0.46) ALDH1A1MAPTKDM4EKMT2APDE10A
SCHEMBL5210215 0.78 BRD4 (0.53) ALDH1A1KDM4EGAANOTUMIDO1
SCHEMBL6603063 0.77 MAP2K1 (0.54) ALDH1A1MAPTKDM4EGAATHRB
SCHEMBL16664833 0.76 MAPT (0.47) ALDH1A1MAPTKDM4EGAATHRB
SCHEMBL1361621 0.76 NOTUM (0.46) NOTUMRAB9APARP1CYP1A2CYP2C9
SCHEMBL16664761 0.76 NOTUM (0.46) NOTUMGCGRKMT2AMEN1IDO1
SCHEMBL7255957 0.73 KDM4E (0.47) ALDH1A1MAPTKDM4EGAATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 EP disclosed
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 EP disclosed
US-10085450-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-22 US disclosed
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-22 US disclosed
EP-3059235-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME Sumitomo Chemical Company, Ltd. (JP) 2016-08-24 EP disclosed
EP-3059235-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME Sumitomo Chemical Company, Ltd. (JP) 2016-08-24 EP disclosed
WO-2015056806-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME 住友化学株式会社 2015-04-23 WO disclosed
CN-1204128-C Process for preparing oxazole derivatives TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-06-01 CN disclosed
US-6699995-B1 ALKYLATION AT 5-POSITION OF OXAZOLE BY REACTION WITH UNSATURATED COMPOUND IN PRESENCE OF ACID OR BASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
EP-1219610-B1 PROCESS FOR THE PREPARATION OF OXAZOLE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-02-25 EP disclosed
CN-1384824-A Process for preparing oxazole derivatives TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-12-11 CN disclosed
EP-0891340-B1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
EP-1219610-A1 PROCESS FOR THE PREPARATION OF OXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-07-03 EP disclosed
EP-0891340-A1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1999-01-20 EP disclosed
WO-1997036882-A1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10085450-B2 Tetrazolinone compound and use thereof ROS1, TCOF1, RPS20 ALDH1A1 970/4885MAPT 3692/4885KDM4E 1468/4885
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF ROS1, TCOF1, RPS20 ALDH1A1 970/4885MAPT 3692/4885KDM4E 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.